Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation

Current Drug Delivery

Volumn 7, Issue 1, 2010, Pages 51-64

  Yadav, Khushwant S ^a   Sawant, Krutika K ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

32 Factorial design, Sustained release; Etoposide; Nanoparticles; PLGA; Stability studies

Indexed keywords

ETOPOSIDE; NANOPARTICLE; POLYMER; SUCROSE;

ARTICLE; BIODEGRADABILITY; DRUG FORMULATION; DRUG STABILITY; EVAPORATION; FREEZE DRYING; HYPERBARISM; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANTINEOPLASTIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DRUG EVALUATION, PRECLINICAL; ETOPOSIDE; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; X-RAY DIFFRACTION;

EID: 77949662784     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720110790396517     Document Type: Article

References (28)

1. Henwood, J. M.; Brogden, R. N. Etoposide: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs, 1990, 39, 438-490.
2. Gilding, D. K.; Reed, A. M. Biodegradable polymers for use in surgery-poly(glycolic)/poly(lactic acid) homo and copolymers. Polymer, 1979, 20, 1459-1464.
3. Shive, M. S.; Anderson, J. M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev., 1997, 28, 5-24.
4. Box, G.; Hunter, W.; Hunter, J. An introduction to design, data analysis and model building. In: Statistics for Experimenters; Wiley: NewYork, 1978, pp. 510-520.
5. Vandervoort, J.; Ludwig, A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int. J. Pharm., 2002, 238, 77-92.
6. Yoo, H. S.; Oh, J. E.; Lee, K. H.; Park, T. G. Biodegradable nanoparticles containing PLGA conjugate for sustained release. Pharm. Res., 1999, 16, 1114-1118.
7. Vandervoort, J.; Ludwig, A., Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study. Pharmazie, 2001, 56, 484-488.
8. McCarron, P. A.; Woolfson, A. D.; Keating, S. M. Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles. Int. J. Pharm., 1999, 193, 37-47.
9. Leo, E.; Brina, B.; Forni, F.; Vandelli, M. A. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int. J. Pharm., 2004, 278, 133-141.
10. Korsmeyer, R. W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N. A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm., 1983, 15, 25-35.
11. Peppas, N. A. Analysis of fickian and non-fickian drug release from polymers. Pharm. Acta. Helv., 1985, 60, 110-111.
12. Reddy, L. H.; Murthy, R.S.R. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS Pharm. Sci. Tech., 2005, 6(2), E-158-E166.
13. Freitas, C.; Muller, R. H. Spray-drying of solid lipid nanoparticles (SLN). Eur. J. Pharm. Biopharm., 1998, 46, 145-151.
14. Ahlin, P.; Kristl, J.; Kristl, A.; Vrecer, F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int. J. Pharm., 2002, 239, 113-120.
15. Hocking, R. R. Analysis and selection of variables in linear regression. Biometrics, 1976, 32, 1-49.
16. Montegomery, D. C. Introduction to factorial designs. In: Design and Analysis of Experiments; John Wiley Sons, New York, 2004, pp. 392-426.
17. Thode, K.; Muller, R. H.; Kresse, M. Two-time window and multiangle photon correlation spectroscopy size and zeta potential analysis-highly sensitive rapid assay for dispersion stability. J. Pharm. Sci., 2000, 89, 1317-1324.
18. Kesisoglou, F.; Panmai, S.; Wu, Y. Nanosizing - Oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev., 2007, 59, 631-644.
19. Sophie-Dorothée, C.; Dalton, C. R.; Hancock, B. C. Differential scanning calorimetry: applications in drug development. Pharm. Sci. Technol. Today, 1999, 2, 311-320.
20. Mandal, T. K.; Bostanian, L. A.; Graves, R. A.; Chapman, S. R.; Womack, I. Development of biodegradable microcapsules as carrier for oral controlled delivery of amifostine. Drug Dev. Ind. Pharm., 2002, 28, 339- 344.
21. Cohen, S.; Yoshiaka, T.; Lucarelli, M. Controlled delivery system for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res., 1991, 8, 713-720.
22. Martinez-Sancho, C.; Herrero-Vanrell, R.; Negro, S. Optimisation of aciclovir poly(d,l-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. Int. J. Pharm., 2004, 273, 45-56
23. Chorny, M.; Fishbein, I.; Danenberg, H. D.; Golomb G. Lipophilic drug loaded nanospheres prepared by nanoparecipitation: effect of formulating variables on size, drug recovery and release kinetics. J. Control. Rel., 2002, 83, 389-400.
24. Park, T. G. Degradation of poly (lactide-co-glycolide acid) microspheres: effect of copolymer composition. Biomaterials, 1995, 16, 1123-1130.
25. Radwan, M. A. In vitro evaluation of polyisobutylcyanoacrylate nanoparticles as a controlled drug carrier for theophylline. Drug Dev. Ind. Pharm., 1995, 21, 2371-2375.
26. Siepmann, J.; Peppas, N. A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev., 2001, 48, 139-157.
27. Gasper, M. M.; Blanco, D.; Cruz, M. E.; Alonso, M. J. Formulation of Lasparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. J. Control. Release, 1998, 52, 53-62.
28. Dunne, M.; Corrigan, O. I.; Ramtoola, Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials, 2000, 21, 1659-1668.